Global Pharma ADMET Testing Market Trends and Growth Analysis 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Pharma ADMET Testing Market Expected To Expand Between 2025 And 2029?

The market size for pharma admet testing has experienced rapid growth in recent years. It is projected to increase from $9.67 billion in 2024 to $10.7 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.6%. The expansion observed in the historical period can be ascribed to factors such as the rise of biopharmaceuticals and biosimilars, an uptick in drug development activities, increasing consciousness about drug safety, the worldwide spread of clinical trials, and a move towards in silico modeling.

The market for pharma admet testing is projected to expand significantly over the coming years. Its valuation is anticipated to reach $17.03 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.3%. This expansion during the forecast period stems from factors such as environmental toxicology and safety assessments, heightened awareness of pharmacogenomics, a strong emphasis on precision medicine, the proliferation of biologics and biosimilars, the incorporation of artificial intelligence (AI), stricter regulatory mandates, and an increase in the development of orphan drugs. Key trends for this period encompass greater research collaborations, swift technological breakthroughs, enhancements in analytical methodologies, ongoing oversight of drug safety, and growing attention to environmental impact.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

Which Drivers Are Impacting The Pharma ADMET Testing Market?

An increasing number of product authorizations is propelling the pharma ADMET testing market. These product approvals denote the procedure through which regulatory bodies, such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe, grant permission for a product to be marketed and sold to the public. ADMET testing is vital for determining the safety and efficacy of novel products and is a mandatory component of product regulatory approvals. For instance, in January 2024, the National Library of Medicine, a US-based biomedical library and a national resource for health professionals, reported that the U.S. Food and Drug Administration (FDA) sanctioned 55 new drugs in 2023, marking an increase from 37 drugs approved in 2022. Consequently, the escalating volume of product approvals fuels the pharma ADMET testing market.

What Are The Leading Segments Analyzed In The Pharma ADMET Testing Market?

The pharma admet testingmarket covered in this report is segmented –

1) By Testing Type: In Vivo ADMET Testing; In Vitro ADMET Testing; In Silico ADMET Testing

2) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology

3) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications

Subsegments:

1) By In Vivo ADMET Testing: Animal Studies; Pharmacokinetics Studies; Toxicology Studies; Biodistribution Studies

2) By In Vitro ADMET Testing: Metabolism Studies; Drug-Drug Interaction Studies; Absorption Studies; Cytotoxicity and Safety Testing

3) By In Silico ADMET Testing: Predictive Modeling and Simulation; Quantitative Structure-Activity Relationship (QSAR) Analysis; Machine Learning Algorithms for ADMET Predictions; Software Tools for ADMET Profiling

Which Market Trends Are Creating New Opportunities In The Pharma ADMET Testing Industry?

Product innovations represent a significant trend gaining traction within the pharma ADMET testing market. Major companies in this market segment are actively launching advanced products, such as Logica, to secure their competitive standing. For example, in April 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company, collaborated with Valo Health Inc., a US-based AI-health solution provider, to introduce Logica, an AI-driven solution for drug development. This innovative solution harnesses Valo’s AI-powered Opal Computational Platform to deliver ADMET testing services and other drug delivery capabilities to users. Logica incorporates premier predictive models, chemical design and synthesis capabilities, DNA encoded libraries, and in silico high throughput screening from Valo’s Opal Computational Platform, complemented by Charles River’s extensive expertise in every facet of discovery optimization, including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, and ultimately safety testing and IND submission.

Who Are The Key Multinational Companies Dominating The Pharma ADMET Testing Market?

Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

How Is Pharma ADMET Testing Market Demand Varying Across Different Regions?

Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pharma ADMET Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12024&type=smp

Browse Through More Reports Similar to the Global Pharma ADMET Testing Market 2025, By The Business Research Company

Healthcare Analytical Testing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-analytical-testing-services-global-market-report

Automotive Testing Inspection And Certification Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automotive-testing-inspection-and-certification-global-market-report

Cold Plasma Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795